News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mayne Pharma.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX health stocks: Mayne Pharma slapped with lawsuit, Patrys encounters clinical trial delays
Health & Biotech
Mayne Pharma shares gain as its new birth control pill wins US approval
News
10 at 10: These ASX stocks have made it to the next stage of their journey this morning
News
Market highlights and 4 ASX small caps to watch on Friday
News
Market highlights and 5 ASX small caps to watch today
Health & Biotech
Medical devices tracker: All the life-saving gadgets ASX companies are working on right now
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s bouncing back today?
Health & Biotech
Mayne Pharma dealt setback for generic contraceptive
Health & Biotech
Nyrada one step closer to cholesterol pill, shares surge
Health & Biotech
ASX investors super happy that FDA may approve first new contraceptive pill in 11 years
News
Short & Caught: The ASX stocks investors are shorting right now
Director Trades
Directors Trades: While most raided supermarkets for toilet paper, these directors raided the stock markets
Health & Biotech
Biotech: It’s not a get-rich-quick scheme judging by these HY reports
News
Here’s the bad news some ASX small caps tried to slip past you over Christmas
Health & Biotech
Health: NZ restricts codeine, painkiller stocks celebrate
Health & Biotech